Additionally, several studies have demonstrated that increased expression or activity of RhoA reduces dendritic length and density, which are alterations observed in the prefrontal cortex of BD patients (Kermath et al. 2020; Konopaske et al. 2014). This evidence concerns the gene RHOA and Behcet disease.